Weight loss telehealth in 2026 means navigating a patchwork of state licensing rules , deciding between cash-pay simplicity versus insurance administrative burden , understanding realistic patient acquisition costs (not the fantasy numbers some platforms advertise), and managing patient retention in a field where dropout rates are high
The main mechanisms include: The strongest outcomes usually occur when GLP-1 medication is combined with protein-focused nutrition, resistance training, walking, sleep improvement, hydration, stress management, and regular physician monitoring
Summary: Retatrutide, an investigational GLP-1/GIP/glucagon triple agonist, most commonly causes gastrointestinal side effects, and no direct human fertility data currently exist, though indirect reproductive benefits via weight loss are plausible
Metabolism: Clinical and Experimental